Onconova Announces Positive Data of Oral Rigosertib in Advanced Head and Neck Cancer

News   Apr 10, 2013

 
Onconova Announces Positive Data of Oral Rigosertib in Advanced Head and Neck Cancer
 
 
 
 

RELATED ARTICLES

U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast Milk

News

The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.

READ MORE

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE